Acute coronary syndrome in patients with type 2 diabetes mellitus

Terapevticheskii Arkhiv

Volumn 83, Issue 9, 2011, Pages 66-70

  Ametov, A S ^a   Pianykh, O P ^a   Aslandzia, E N ^a  

^a Russian Medical Academy of Advanced Medical Training   (Russian Federation)

Author keywords

Acute coronary syndrome; Diabetes mellitus; Myocardial infarction; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT;

ACUTE CORONARY SYNDROME; ARTICLE; CARBOHYDRATE METABOLISM; DRUG EFFECT; HUMAN; INSULIN RESISTANCE; METABOLISM; MORTALITY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS;

ACUTE CORONARY SYNDROME; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MORTALITY; MULTICENTER STUDIES AS TOPIC; PROGNOSIS;

EID: 80555131795     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Juutilainen A. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27: 2898-2904. (Pubitemid 39565056)
2. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur. Heart J. 2007; 28: 88-136.
3. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J. 1998; 317: 703-713.
4. Adler A., Stratton I. M., Neil H. et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br. Med. J. 2000; 321: 412-419. (Pubitemid 30609443)
5. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J. Hypertens. 2007; 25: 1105-1187.
6. Stratton I. M., Adler A. I., Neil H. A. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br. Med. J. 2000; 321: 405-412. (Pubitemid 30609442)
7. Marso S. P., Lincoff M., Ellis S. G. et al. Optimizing the percutaneous outcome for patients with diabetes mellitus. Results of the EPISCENT Diabetic Substudy. Circulation 1999; 100: 2477-2484.
8. Marks J. B., Raskin P. Cardiovascular risk in diabetes. J. Diabet. Complicat. 2000; 14: 108-115.
9. Norhammar A., Malmberg K., Ryden L. et al. Under-utilisation of evidence-based treatment partial explanation for the unfavorable prognosis in diabetic patients with acute myocardial infarction. Eur. Heart J. 2003; 24: 838-844. (Pubitemid 36528563)
10. Otter W., Kleybrink S., Doerig W. et al. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabetes Med. 2004; 21: 183-187. (Pubitemid 38221819)
11. De Groot M., Auslander W., Williams J. H. et al. Depression and poverty among african american women at risk for type 2 diabetes. Ann. Behav. Med. 2003; 25(3): 172-181. (Pubitemid 36705917)
12. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur. Heart J. 1988; 9: 256-264.
13. Gustafsson I., Hildebrandt P., Seibaek M. et al. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE. Study Group. Eur. Heart J. 2000; 21: 1937-1943.
14. Angular D., Solomon S., Kober L. et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute miocardial infarction, the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Circulation 2004; 21: 1572-
15. Goyal A., Mahaffey K., Gard J. et al. Prognostic significance of the change in glucose level in the first 24h after acute myocardial infarction, results from the CARDINAL study. Eur. Heart J. 2006; 27: 1289-1297. (Pubitemid 43998101)
16. Bartnik M., Ryden L., Ferrari R. et al. Euro Heart Survei Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Eur. Heart J. 2004; 25: 1880-1890. (Pubitemid 39452604)
17. Malmberg K., Norhammar A., Ryden L. et al. Glucometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study. Circulation 1999; 99: 2626-2632. (Pubitemid 29237448)
18. Van den Berghe G., Wouters P. J., Weekers F. et al. Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 2001; 345: 1359-1367.
19. Malmberg K., Ryden L., Efendic S. et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J. Am. Coll. Cardiol. 1995; 26: 57-65.
20. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br. Med. J. 1997; 314: 1512-1515. (Pubitemid 27216066)
21. Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur. Heart J. 2000; 21: 1502-1516.
22. De Backer G., Ambrosioni E., Borch-Johnsen K. et al. European Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2003; 24: 1601-1610.
23. Liebl A., Mata M., Eschwege E. Evaluation of risk factors for development of complications in type 2 diabetes in Europe. Diabetologia 2002; 45: S23-S28. (Pubitemid 34762211)
24. Brown J. B., Nichols G. A. Slow response to loss of glycemie control in type 2 diabetes mellitus. Am. J. Manag. Care 2003; 9: 213-217. (Pubitemid 36372212)
25. Gudbjernsdottir S., Cederholm J., Nilsson P. M. et al. The National Diabetes Register in Sweden: an implementation of the St Vincent declaration for quality improvements in diabetes care. Diabetes Care 2003; 26: 1270-1276. (Pubitemid 36929284)
26. Malmberg K., Ryden L., Wedel H. et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and\ acute myocardial infarction (DIGAMI2): effects on mortality and morbidity. Eur. Heart J. 2005; 26: 650-661.
27. Van den Berghe G., Wouters P. J., Bouillon R. et al. Outcome benefit of insulin therapy in the critical ill: insulin dose versus glycemie control. Crit. Care Med. 2003; 31: 359-366. (Pubitemid 36232926)
28. Gitt A., Schiele R., Wienbergen H. et al. MITRA study. Intensive treatment of coronary artery disease in diabetic patients in clinical pactice: results of the MITRA study. Acta Diabetol. 2003; 40: S343-S347.
29. Schnell O., Doering W., Schefer O. et al. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction. The Munich registry. Diabetes Care 2004; 27: 455-460.